{"count": 3, "results": [{"_id": "37744021", "pmid": 37744021, "pmcid": "PMC10514453", "title": "Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis", "journal": "Osteoarthr Cartil Open", "authors": ["Cicuttini FM", "Proietto J", "Lim YZ"], "date": "2023-09-09T00:00:00Z", "doi": "10.1016/j.ocarto.2023.100407", "meta_date_publication": "2023 Dec", "meta_volume": "5", "meta_issue": "4", "meta_pages": "100407", "score": 50249.168, "text_hl": "We propose a combined approach of @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ when indicated, together with targeting @DISEASE_Larva_Migrans @DISEASE_MESH:D007815 @@@weight creep@@@ across adult years and the potential role of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Implementing these combined approaches is likely to be more effective in improving @SPECIES_9606 @@@patient@@@ related outcomes, reducing @<m>DISEASE_Joint_Diseases</m> @DISEASE_MESH:D007592 @@@joint damage@@@ and healthcare costs, than our current focus on achieving @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ in @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@OA@@@.", "citations": {"NLM": "Cicuttini FM, Proietto J, Lim YZ. Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis Osteoarthr Cartil Open. 2023 Dec;5(4):100407. PMID: 37744021", "BibTeX": "@article{37744021, title={Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis}, author={Cicuttini FM and Proietto J and Lim YZ}, journal={Osteoarthr Cartil Open}, volume={5}, number={4}, pages={100407}}"}}, {"_id": "30584213", "pmid": 30584213, "title": "Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes.", "journal": "Biosci Trends", "authors": ["Wang C", "Yang Y", "Zhang Y", "Liu J", "Yao Z", "Zhang C"], "date": "2019-01-22T00:00:00Z", "doi": "10.5582/bst.2018.01263", "meta_date_publication": "2019 Jan 22", "meta_volume": "12", "meta_issue": "6", "meta_pages": "605-612", "score": 50041.2, "text_hl": "Overall, our findings provide evidence that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ suppresses @GENE_IL1B @GENE_3553 @@@IL-1beta@@@-induced oxidative and @DISEASE_Osteoarthritis @DISEASE_MESH:D010003 @@@osteoarthritis@@@-like @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ changes by enhancing the @GENE_SIRT3 @GENE_64384 @@@SIRT3@@@/@GENE_PINK1 @GENE_68943 @@@PINK1@@@/Parkin signaling pathway, thereby indicating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s potential in prevention and treatment of @<m>DISEASE_Joint_Diseases</m> @DISEASE_MESH:D007592 @@@osteoarthritic joint disease@@@.", "citations": {"NLM": "Wang C, Yang Y, Zhang Y, Liu J, Yao Z, Zhang C. Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes. Biosci Trends. 2019 Jan 22;12(6):605-612. PMID: 30584213", "BibTeX": "@article{30584213, title={Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes.}, author={Wang C and Yang Y and Zhang Y and Liu J and Yao Z and Zhang C}, journal={Biosci Trends}, volume={12}, number={6}, pages={605-612}}"}}, {"_id": "31278727", "pmid": 31278727, "title": "Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS.", "journal": "Pak J Pharm Sci", "authors": ["Ayub M", "Gul S", "Zehra F"], "date": "2019-05-01T00:00:00Z", "meta_date_publication": "2019 May", "meta_volume": "32", "meta_issue": "3", "meta_pages": "1107-1110", "score": 50040.95, "text_hl": "Its off-label use is still controversial with unknown mechanisms due to @SPECIES_9606 @@@patient@@@ risk versus benefit hypothesis by practitioners as they successfully treat @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ in adolescents with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. But in few reported cases @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has potential to induce @DISEASE_Back_Pain @DISEASE_MESH:D001416 @@@back pain@@@ and @<m>DISEASE_Joint_Diseases</m> @DISEASE_MESH:D007592 @@@swollen joints@@@ less frequently with rare cases of behavior alteration. ", "citations": {"NLM": "Ayub M, Gul S, Zehra F. Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS. Pak J Pharm Sci. 2019 May;32(3):1107-1110. PMID: 31278727", "BibTeX": "@article{31278727, title={Report: Metformin potential in predisposing arthralgia, type II cross reactivity secondary to group A streptococcus infection & other comorbidities in treating PCOS.}, author={Ayub M and Gul S and Zehra F}, journal={Pak J Pharm Sci}, volume={32}, number={3}, pages={1107-1110}}"}}]}